Showing papers by "Aydın Aktaş published in 2022"
TL;DR: Imidazolidine-functionalized Ru(II)NHC complexes containing naphthyl substitute group were synthesized and in vitro anticancer activity as well as DNA binding properties using agarose gel electrophoresis and ethidium bromide fluorescence quenching assay methods were determined in order to understand the biological activities.
8 citations
TL;DR: The first COVID19 vaccine to humans worldwide was administered in the UK on December 20, 2020 (BioNTech). In our country, vaccination started on January 13, 2021 (CoronaVac) as mentioned in this paper .
Abstract: Dear Editor, The first COVID19 vaccine to humans worldwide was administered in the UK on December 20, 2020 (BioNTech). In our country, vaccination started on January 13, 2021 (CoronaVac). As the vaccination rate increases worldwide, cutaneous reactions such as local injection site reactions, urticaria, cutaneous eruptions, herpes simplex, herpes zoster, pernio, and reactions related to cosmetic filler injections are reported.1– 3
TL;DR: Endoscopic submucosal dissection is an effective and relatively safe method in endoscopic mucosal resection interrupted colorectal laterally spreading tumors.
Abstract: Aim: Endoscopic mucosal resection might technically be unsuccessful (interrupted endoscopic mucosal resection) in some cases when treating large colorectal laterally spreading tumors. In the literature, data on the outcomes of the endoscopic submucosal dissection method in endoscopic mucosal resection interrupted tumors are lacking. In this study, we evaluated the results of patients who underwent endoscopic submucosal dissection for endoscopic mucosal resection interrupted laterally spreading tumors.
Materials and Methods: Between February 2019 and April 2021, 8 patients with endoscopic mucosal resection interrupted colorectal laterally spreading tumors underwent endoscopic submucosal dissection. The primary endpoint was en bloc, R0, and curative resection rates of endoscopic submucosal dissection.
Results: In all cases, endoscopic submucosal dissection was successfully completed. The mean tumor size was 61.5 mm (35–100 mm). The rate of en bloc resection, R0 resection and curative resection was 100%, 87.5% and 87.5% respectively. Intra-procedural perforation occurred in 1 patient (12.5%) and was successfully treated with clip application. Delayed bleeding occurred in 1 patient (12.5%), and was successfully treated with endoluminal hemostasis. Furthermore, histopathological examination revealed that laterally spreading tumors in 4 patients (50.0%) had submucosal invasion. Surgical resection was performed after endoscopic submucosal dissection in 1 patient owing to the presence of deep submucosal invasion.
Conclusion: Endoscopic submucosal dissection is an effective and relatively safe method in endoscopic mucosal resection interrupted colorectal laterally spreading tumors.
01 Apr 2022